185 related articles for article (PubMed ID: 35378058)
21. Cationic Surfactant-Natural Clay Complex as a Novel Agent Against Acanthamoeba castellanii Belonging to the T4 Genotype.
Akbar N; Siddiqui R; Khamis M; Ibrahim T; Khan NA
Eye Contact Lens; 2021 Nov; 47(11):592-597. PubMed ID: 34173368
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches.
Sebastián-Pérez V; Sifaoui I; Reyes-Batlle M; Domínguez-De Barros A; López-Arencibia A; Campillo NE; Piñero JE; Lorenzo-Morales J; Gil C
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229426
[TBL] [Abstract][Full Text] [Related]
23. Lactase can target cellular differentiation of Acanthamoeba castellanii belonging to the T4 genotype.
Simau FA; Ahmed U; Khan KM; Khan NA; Siddiqui R; Alharbi AM; Alfahemi H; Anwar A
Parasitol Res; 2024 Jan; 123(2):117. PubMed ID: 38294565
[TBL] [Abstract][Full Text] [Related]
24. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
[No Abstract] [Full Text] [Related]
25. Methanolic extract of Peganum harmala exhibit potent activity against Acanthamoeba castellanii cysts and its encystment in vitro.
Shohaib HM; Nawaz S; Matin A
Pak J Pharm Sci; 2016 Nov; 29(6):1993-1996. PubMed ID: 28375115
[TBL] [Abstract][Full Text] [Related]
26. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
27. Isobenzofuran-1(3H)-one derivatives: Amoebicidal activity and program cell death in Acanthamoeba castellanii Neff.
Rodríguez-Expósito RL; Reyes-Batlle M; Sifaoui I; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2022 Jun; 150():113062. PubMed ID: 35658232
[TBL] [Abstract][Full Text] [Related]
28. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
29. The amoebicidal activity of three substances derived from benzothiazole on Acanthamoeba castellanii cysts and trophozoites and its cytotoxic potentials.
Ozpinar N; Culha G; Kaya T; Yucel H
Acta Trop; 2021 Aug; 220():105981. PubMed ID: 34048787
[TBL] [Abstract][Full Text] [Related]
30. Antiamoebic properties of salicylic acid-based deep eutectic solvents for the development of contact lens disinfecting solutions against Acanthamoeba.
Siddiqui R; Makhlouf Z; Akbar N; Khamis M; Ibrahim T; Khan AS; Khan NA
Mol Biochem Parasitol; 2022 Jul; 250():111493. PubMed ID: 35753525
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of nanoparticles with 5-fluorouracil and chloroquine on Acanthamoeba castellanii activity.
Saeed BQ; Qalaji MR; Akbar N; Siddiqui R; Roberta C; Manzoor S; Muhammad JS; Adrees AO; Al-Shahrabi R; Khan NA
Mol Biochem Parasitol; 2022 Jul; 250():111492. PubMed ID: 35714753
[TBL] [Abstract][Full Text] [Related]
32. Amoebicidal activity of benzothiazole on Acanthamoeba castellanii cysts and trophozoites and its cytotoxic potentials.
Ozpinar N; Ozpinar H; Bakay BB; Tunc T
Acta Trop; 2020 Mar; 203():105322. PubMed ID: 31887263
[TBL] [Abstract][Full Text] [Related]
33. Novel Antiamoebic Tyrocidine-Derived Peptide against Brain-Eating Amoebae.
Akbar N; Kaman WE; Sarink M; Nazmi K; Bikker FJ; Khan NA; Siddiqui R
ACS Omega; 2022 Aug; 7(33):28797-28805. PubMed ID: 36033708
[No Abstract] [Full Text] [Related]
34. Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.
Deng Y; Ran W; Man S; Li X; Gao H; Tang W; Tachibana H; Cheng X
Antimicrob Agents Chemother; 2015 Aug; 59(8):4680-8. PubMed ID: 26014935
[TBL] [Abstract][Full Text] [Related]
35. Novel Plant-Based Metabolites as Disinfectants against
Siddiqui R; Akbar N; Khatoon B; Kawish M; Ali MS; Shah MR; Khan NA
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203850
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba.
Thomson S; Rice CA; Zhang T; Edrada-Ebel R; Henriquez FL; Roberts CW
Sci Rep; 2017 Aug; 7(1):8247. PubMed ID: 28811501
[TBL] [Abstract][Full Text] [Related]
37. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
Siddiqui R; Lakhundi S; Iqbal J; Khan NA
Exp Parasitol; 2016 Sep; 168():45-50. PubMed ID: 27381503
[TBL] [Abstract][Full Text] [Related]
38. In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.
Baig AM; Iqbal J; Khan NA
Antimicrob Agents Chemother; 2013 Aug; 57(8):3561-7. PubMed ID: 23669391
[TBL] [Abstract][Full Text] [Related]
39. Nanovesicles containing curcumin hold promise in the development of new formulations of anti-Acanthamoebic agents.
Saeed BQ; Hussain K; Akbar N; Khan H; Siddiqui R; Shah RM; Khan NA
Mol Biochem Parasitol; 2022 Jan; 247():111430. PubMed ID: 34813865
[TBL] [Abstract][Full Text] [Related]
40. Homodimerization Counteracts the Detrimental Effect of Nitrogenous Heme Ligands on the Enzymatic Activity of
Nienhaus K; Sharma V; Nienhaus GU; Podust LM
Biochemistry; 2022 Jul; 61(13):1363-1377. PubMed ID: 35730528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]